Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified. more
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | 1.67% | 0.03% |
| 1-Month Return | 4.3% | -0.06% |
| 3-Month Return | 10.26% | 10.73% |
| 6-Month Return | -4.04% | 8.19% |
| 1-Year Return | 28.42% | 22.21% |
| 3-Year Return | 15.11% | 70.13% |
| 5-Year Return | -24.73% | 73.43% |
| 10-Year Return | 47.66% | 254.69% |
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | 137.17% | 1.58% |
| 1-Month Return | 66.90% | -0.73% |
| 3-Month Return | 48.60% | 51.19% |
| 6-Month Return | -8.02% | 17.31% |
| 1-Year Return | 28.42% | 22.21% |
| 3-Year Return | 4.80% | 19.38% |
| 5-Year Return | -5.52% | 11.64% |
| 10-Year Return | 3.97% | 13.50% |
| Stock name | Ticker | Weight |
|---|---|---|
GUARDANT HEALTH INC | GH | 9% |
NATERA INC | NTRA | 6.81% |
KRYSTAL BIOTECH INC | KRYS | 5.85% |
UNITED THERAPEUTICS CORP | UTHR | 3.96% |
LIGAND PHARMACEUTICALS | LGND | 3.85% |
ADAPTIVE BIOTECHNOLOGIES | ADPT | 3.75% |
BRIDGEBIO PHARMA INC | BBIO | 3.53% |
ELI LILLY & CO | LLY | 3.09% |
ASTRAZENECA PLC | AZN.L | 2.89% |
VERTEX PHARMACEUTICALS IN | VRTX | 2.73% |
INSMED INC | INSM | 2.68% |
SAMSUNG BIOLOGICS CO LTD | 207940.KS | 2.47% |
CORTEVA INC | CTVA | 2.3% |
TWIST BIOSCIENCE CORP | TWST | 2.29% |
CASH | CASH | 2.21% |
ALNYLAM PHARMACEUTICALS I | ALNY | 2.2% |
TRAVERE THERAPEUTICS INC | TVTX | 2.14% |
MEDPACE HOLDINGS INC | MEDP | 2.08% |
NEUROCRINE BIOSCIENCES IN | NBIX | 2.04% |
REGENERON PHARMACEUTICALS | REGN | 2.02% |
IONIS PHARMACEUTICALS INC | IONS | 2.02% |
TEMPUS AI INC-CL A | TEM | 1.96% |
ARGENX SE | ARGX.BR | 1.67% |
VERACYTE INC | VCYT | 1.56% |
BIONTECH SE-ADR | BNTX | 1.49% |
PTC THERAPEUTICS INC | PTCT | 1.41% |
STOKE THERAPEUTICS INC | STOK | 1.37% |
CADENCE DESIGN SYS INC | CDNS | 1.19% |
GRAIL INC | GRAL | 1.18% |
CHARLES RIVER LABORATORIE | CRL | 1.16% |
CRISPR THERAPEUTICS AG | CRSP | 1.14% |
SARTORIUS AG-VORZUG | SRT3.DE | 1.05% |
REPLIGEN CORP | RGEN | 1.02% |
BEAM THERAPEUTICS INC | BEAM | 0.99% |
ANAPTYSBIO INC | ANAB | 0.89% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 0.87% |
AXSOME THERAPEUTICS INC | AXSM | 0.87% |
CATALYST PHARMACEUTICALS | CPRX | 0.86% |
THERMO FISHER SCIENTIFIC | TMO | 0.81% |
IQVIA HOLDINGS INC | IQV | 0.81% |
PRAXIS PRECISION MEDICINE | PRAX | 0.76% |
CAREDX INC | CDNA | 0.74% |
AGILENT TECHNOLOGIES INC | A | 0.68% |
DANAHER CORP | DHR | 0.63% |
HINGE HEALTH INC-A | HNGE | 0.59% |
QIAGEN N.V. | QIA.DE | 0.51% |
ULTRAGENYX PHARMACEUTICAL | RARE | 0.48% |
SAMSUNG EPISHOLDINGS CO L | 0126Z0.KS | 0.45% |
ARCUTIS BIOTHERAPEUTICS I | ARQT | 0.39% |
RHYTHM PHARMACEUTICALS IN | RYTM | 0.37% |
BIO-RAD LABORATORIES-A | BIO | 0.3% |
KINIKSA PHARMACEUTICALS I | KNSA | 0.29% |
TARSUS PHARMACEUTICALS IN | TARS | 0.27% |
BRISTOL-MYERS SQUIBB CO | BMY | 0.27% |
BEONE MEDICINES LTD-ADR | ONC | 0.25% |
NEUROGENE INC | NGNE | 0.22% |
FIRST TRACKS BIOTHERAPEUT | TRAXV | 0.2% |
GENEDX HOLDINGS CORP | WGS | 0.13% |
WAVE LIFE SCIENCES LTD | WVE | 0.12% |
RECURSION PHARMACEUTICALS | RXRX | 0.08% |
Net Current Assets | Net.Current.Assets | 0.04% |
OMNIAB INC - 15.00 EARNOU | 2200964 | 0% |
OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
| Sector | Weight |
|---|---|
|
Health care | 96.31% |
|
Materials | 2.44% |
|
Information Technology | 1.25% |
Franklin Genomic Advancements ETF (HELX) share price today is $35.43.
Yes, Indians can buy shares of Franklin Genomic Advancements ETF (HELX) on Vested. To buy HELX from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Franklin Genomic Advancements ETF (HELX) on Vested. You can start investing in Franklin Genomic Advancements ETF (HELX) with a minimum investment of $1.
The 52-week high price of Franklin Genomic Advancements ETF (HELX) is $38.17. The 52-week low price of Franklin Genomic Advancements ETF (HELX) is $26.8.
The stock symbol (or ticker) of Franklin Genomic Advancements ETF is HELX.
Yes, you can setup SIP in Franklin Genomic Advancements ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of HELX on the Vested app.
The expense ratio of Franklin Genomic Advancements ETF (HELX) is 0.5%.
Link copied